Physician profile
Peyton Johnson
NPI 1497146682
$5,016.16
in general payments reported to CMS, 2019-2025
10 companies · $2,316 in 2025
The $2,316 reported for 2025 was more than what 81% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $197 · 2023: $98.24 · 2024: $2,404 · 2025: $2,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,760 · Travel and Lodging: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,760.09 |
| Travel and Lodging | $2,058.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,848.88 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $1,240.91 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $976.41 | 2025 | Proclaim, Eterna, Durata |
| Spr Therapeutics, INC | $441.68 | 2022-2025 | Sprint Pns System |
| Globus Medical, INC. | $177.14 | 2025 | Senza |
| Spinal Simplicity, LLC | $123.13 | 2025 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $109.77 | 2025 | |
| Emd Serono, INC. | $43.34 | 2023 | Mavenclad |
| Abbvie INC. | $31.51 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.39 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peyton Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.